Four kinds of ophthalmic drugs commonly used in the treatment of glaucoma

Abstract: we know that the risk factor of glaucoma is abnormally elevated intraocular pressure. If the intraocular pressure exceeds the tolerance range of the eyeball, it will lead to visual impairment and even blindness in severe cases.

we know that the risk factor of glaucoma is abnormally elevated intraocular pressure. If the intraocular pressure exceeds the tolerance range of the eyeball, the long-term development will lead to visual impairment and even blindness. Therefore, it is very important to maintain the stability of intraocular pressure for a long time. Intraocular pressure can be controlled by drugs. It is one of the treatment schemes for glaucoma. The drug treatment for glaucoma is not single, and which eye drugs are suitable for you? This is the most concerned problem of glaucoma patients.

in this regard, the editor will introduce four commonly used glaucoma treatment drugs –

one by one. Carbonic anhydrase inhibitor

carbonic anhydrase inhibitor has two kinds: oral agent and eye drops. The commonly used eye drops are 1% brinzolamide (pirimide). The dosage of eye drops is generally 2-3 times a day. Common side effects of oral carbonic anhydrase inhibitors include nausea and diarrhea, and eye drops can largely avoid these reactions.

II. Prostaglandin derivative drugs

, the latest drugs for the treatment of glaucoma, have gradually become the international drug treatment trend, mainly including travoprost (sulvestan) and latanoprost. Prostaglandin derivative drugs will cause ocular congestion, but will gradually weaken with the extension of medication time.

III α- The receptor agonist

bromonidine is the most common α- The dosage of receptor agonist is generally 2-3 times a day. It has almost no effect of reducing intraocular pressure at night. Side effects include allergic reaction and drowsiness of eyes.

IV β- Receptor Yin retardants

β- Receptor Yin stagnation agent has been used clinically for more than ten years, timolol is the most commonly used β- Receptor Yin stagnation agent. β- The dosage of receptor Yin stagnation agent is generally twice a day. Its effect of reducing intraocular pressure at night is weakened. At the same time, it is forbidden for patients with severe heart disease, atrioventricular block, sinus bradycardia, hypotension, asthma and obstructive pulmonary disease.

shared:

people who read this article should take care of their eyes. The following products are more >

compound Xueshuantong capsule: promoting blood circulation and removing blood stasis, supplementing qi and nourishing yin. It is used to treat retinal vein occlusion with blood stasis and deficiency of Qi and Yin, such as decreased vision or abnormal vision, signs of fundus blood stasis, mental fatigue, dry throat, dry mouth, etc; And stable tired angina pectoris for blood stasis and deficiency of Qi and Yin. Symptoms include chest tightness and pain, palpitation, palpitation, palpitation, shortness of breath, fatigue, upset and dry mouth. Citicoline sodium capsule: used to treat the sequelae of nervous system caused by craniocerebral injury or cerebrovascular accident.

price: ¥ 668

has a good effect on reducing intraocular pressure in primary open-angle glaucoma. For some secondary glaucoma, ocular hypertension, some primary angle closure glaucoma and glaucoma with ineffective drugs and surgery, the addition of this product can further enhance the effect of reducing intraocular pressure.

price: ¥ 9.9

has a good effect on reducing intraocular pressure in primary open-angle glaucoma. For some secondary glaucoma, ocular hypertension, some primary angle closure glaucoma and glaucoma with ineffective drugs and surgery, the addition of this product can further enhance the effect of reducing intraocular pressure.

price: ¥ 13

has a good effect on reducing intraocular pressure in primary open-angle glaucoma. For some secondary glaucoma, ocular hypertension, some primary angle closure glaucoma and glaucoma with ineffective drugs and surgery, the addition of this product can further enhance the effect of reducing intraocular pressure. Price of

and

: ¥ 20

and

are used to treat uveitis, keratitis and scleritis, inhibit the formation of corneal neovascularization, treat the inflammatory reaction after intraocular surgery, laser curtain forming or various eye injuries, and inhibit the mydriasis reaction in cataract surgery; Used for analgesia and anti-inflammatory after excimer laser keratectomy; Allergic eye diseases such as spring conjunctivitis and seasonal allergic conjunctivitis, prevent and treat inflammation and macular cystoid edema after cataract and intraocular lens surgery, and promote the formation of filtering blebs after glaucoma filtering surgery.

price: ¥ 21

for acute angle closure glaucoma, chronic angle closure glaucoma, open angle glaucoma, secondary glaucoma, etc. This product can be combined with other mydriasis agents β Receptor blockers, carbonic anhydrase inhibitors, sympathetic drugs or hypertonic dehydrating agents are used in the treatment of glaucoma. After ophthalmoscopy, this product can be dripped to shrink the pupil to counteract the effect of ciliary muscle paralysis agent or pupil dilator.

price: ¥ 7

is suitable for reducing elevated intraocular pressure in the following cases: high intraocular pressure, open-angle glaucoma can be used as a treatment for β Blockers are ineffective, or patients with contraindications use separate therapeutic drugs, or as β Synergistic therapeutic drugs of blockers.

price: ¥ 70

this product can effectively reduce intraocular pressure and is used for the treatment of patients with chronic open-angle glaucoma and / or ocular hypertension. It can be used alone or in combination with other drugs to reduce intraocular pressure.

and

price: ¥ 52

and

are used for internal diseases such as Sjogren’s syndrome, Sjogren’s syndrome, xerophthalmia and various external diseases. It is especially suitable for patients with Sjogren’s syndrome and Sjogren’s syndrome who need long-term medication. Price of

and

: ¥ 49

and

are used to treat uveitis, keratitis and scleritis, inhibit the formation of corneal neovascularization, treat the inflammatory reaction after intraocular surgery, laser curtain forming or various eye injuries, and inhibit the mydriasis reaction in cataract surgery; Used for analgesia and anti-inflammatory after excimer laser keratectomy; Allergic eye diseases such as spring conjunctivitis and seasonal allergic conjunctivitis, prevent and treat inflammation and macular cystoid edema after cataract and intraocular lens surgery, and promote the formation of filtering blebs after glaucoma filtering surgery.

price:¥, prostaglandin derivatives can cause eye congestion, but it will gradually weaken with the extension of medication time.

III α- The receptor agonist

bromonidine is the most common α- The dosage of receptor agonist is generally 2-3 times a day. It has almost no effect of reducing intraocular pressure at night. Side effects include allergic reaction and drowsiness of eyes.

IV β- Receptor Yin retardants

β- Receptor Yin stagnation agent has been used clinically for more than ten years, timolol is the most commonly used β- Receptor Yin stagnation agent. β- The dosage of receptor Yin stagnation agent is generally twice a day. Its effect of reducing intraocular pressure at night is weakened. At the same time, it is forbidden for patients with severe heart disease, atrioventricular block, sinus bradycardia, hypotension, asthma and obstructive pulmonary disease.

, I. carbonic anhydrase inhibitor. Carbonic anhydrase inhibitor includes oral agent and eye drops. The commonly used eye drops are: 1% brinzolamide (pirimidine). The dosage of eye drops is generally 2-3 times a day. Common side effects of oral carbonic anhydrase inhibitors include nausea and diarrhea, and eye drops can largely avoid these reactions., 2. Prostaglandin derivatives, the latest drugs for the treatment of glaucoma, have gradually become an international drug treatment trend, mainly including travoprost (sulvestan) and latanoprost. Prostaglandin derivatives will cause ocular congestion, but will gradually weaken with the extension of medication time., III α- Of the receptor agonists, bromonidine is the most common α- The dosage of receptor agonist is generally 2-3 times a day. It has almost no effect of reducing intraocular pressure at night. Side effects include allergic reaction and drowsiness of eyes., IV β- Receptor Yin retardants β- Receptor Yin stagnation agent has been used clinically for more than ten years, timolol is the most commonly used β- Receptor Yin stagnation agent. β- The dosage of receptor Yin stagnation agent is generally twice a day. Its effect of reducing intraocular pressure at night is weakened. At the same time, it is forbidden for patients with severe heart disease, atrioventricular block, sinus bradycardia, hypotension, asthma and obstructive pulmonary disease.